Regenxbio
RGNX
Regenxbio (RGNX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Baird | Maintained | Outperform | $29.00 from $32.00 | Aug 25, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 from $23.00 | Aug 25, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $23.00 from $26.00 | Aug 10, 2026 |
| Barclays | Downgraded | Overweight → Equal-Weight | $12.00 | Aug 7, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 | Jun 24, 2026 |
| Leerink Partners | Maintained | Outperform | $18.00 from $17.00 | Jun 22, 2026 |
| Baird | Maintained | Outperform | $32.00 from $27.00 | Jun 22, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 from $30.00 | Jun 5, 2026 |
| Barclays | Maintained | Overweight | $12.00 from $37.00 | May 15, 2026 |
| B of A Securities | Maintained | Buy | $14.00 from $25.00 | May 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 from $32.00 | Mar 9, 2026 |
| Morgan Stanley | Maintained | Overweight | $17.00 from $18.00 | Mar 6, 2026 |
| Chardan Capital | Maintained | Buy | $50.00 from $52.00 | Feb 10, 2026 |
| Morgan Stanley | Maintained | Overweight | $18.00 from $25.00 | Feb 10, 2026 |
| Goldman Sachs | Maintained | Neutral | $12.00 from $14.00 | Feb 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 from $34.00 | Feb 10, 2026 |
| Chardan Capital | Maintained | Buy | $52.00 | Jan 29, 2026 |
| Stifel | Maintained | Buy | $45.00 from $40.00 | Dec 19, 2025 |
| Leerink Partners | Maintained | Outperform | $20.00 from $16.00 | Dec 15, 2025 |
| Chardan Capital | Maintained | Buy | $52.00 | Nov 20, 2025 |
Frequently asked questions
What is the latest analyst rating on RGNX?
On Aug 25, 2026, Baird maintained Regenxbio at Outperform with a price target of $29.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.